Cell MedX Corp. – ‘10-K’ for 5/31/21 – ‘EX-21.1’

On:  Monday, 8/30/21, at 5:06pm ET   ·   For:  5/31/21   ·   Accession #:  1393905-21-393   ·   File #:  0-54500

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Annual Report   —   Form 10-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Cell Medx Corp. - Form 10-K SEC Filing              HTML    680K 
 2: EX-10.36    Loan Agreement and Note Payable Dated March 29,     HTML     27K 
                2021                                                             
 3: EX-10.37    Loan Agreement and Note Payable Dated April 15,     HTML     27K 
                2021                                                             
 4: EX-10.38    Loan Agreement and Note Payable Dated May 18, 2021  HTML     27K 
 5: EX-10.41    Loan Agreement and Note Payable Dated June 22,      HTML     27K 
                2021                                                             
 6: EX-21.1     List of Significant Subsidiaries                    HTML     23K 
 7: EX-31.1     Certification -- §302 - SOA'02                      HTML     26K 
 8: EX-31.2     Certification -- §302 - SOA'02                      HTML     26K 
 9: EX-32.1     Certification -- §906 - SOA'02                      HTML     23K 
10: EX-32.2     Certification -- §906 - SOA'02                      HTML     24K 
17: R1          Document and Entity Information                     HTML     78K 
18: R2          Consolidated Balance Sheets                         HTML    107K 
19: R3          Consolidated Statements of Operations               HTML    100K 
20: R4          Consolidated Statement of Stockholders' Deficit     HTML     84K 
21: R5          Consolidated Statements of Cash Flows               HTML    104K 
22: R6          Organization and Nature of Operations               HTML     29K 
23: R7          Summary of Significant Accounting Policies          HTML     41K 
24: R8          Related Party Transactions Disclosure               HTML     43K 
25: R9          Inventory Disclosure                                HTML     26K 
26: R10         Other Current Assets Disclosure                     HTML     26K 
27: R11         Equipment Disclosure                                HTML     32K 
28: R12         Revenue Disclosure                                  HTML     32K 
29: R13         Distribution Rights Disclosure                      HTML     34K 
30: R14         Notes and Advances Payable Disclosure               HTML     54K 
31: R15         Share Capital Disclosure                            HTML     60K 
32: R16         Income Taxes Disclosure                             HTML     44K 
33: R17         Subsequent Events Disclosure                        HTML     27K 
34: R18         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Basis   HTML     26K 
                of Presentation (Policies)                                       
35: R19         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:         HTML     27K 
                Principles of Consolidation, Policy (Policies)                   
36: R20         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:         HTML     28K 
                Accounting Estimates, Policy (Policies)                          
37: R21         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:         HTML     27K 
                Foreign Currency Translations and Transactions,                  
                Policy (Policies)                                                
38: R22         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:         HTML     27K 
                Revenue Recognition, Policy (Policies)                           
39: R23         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:         HTML     28K 
                Inventory Valuation, Policy (Policies)                           
40: R24         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:         HTML     27K 
                Research and Development Costs, Policy (Policies)                
41: R25         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Income  HTML     29K 
                Taxes, Policy (Policies)                                         
42: R26         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Loss    HTML     27K 
                Per Share, Policy (Policies)                                     
43: R27         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:         HTML     27K 
                Long-lived Assets, Policy (Policies)                             
44: R28         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:         HTML     27K 
                Equipment, Policy (Policies)                                     
45: R29         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Fair    HTML     28K 
                Value Measurements, Policy (Policies)                            
46: R30         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Stock   HTML     27K 
                Options and Other Stock-based Compensation, Policy               
                (Policies)                                                       
47: R31         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Recent  HTML     26K 
                Accounting Pronouncements (Policies)                             
48: R32         Related Party Transactions Disclosure: Schedule of  HTML     33K 
                Amounts Due to Related Parties (Tables)                          
49: R33         Related Party Transactions Disclosure: Schedule of  HTML     32K 
                Transactions with Related Parties (Tables)                       
50: R34         Equipment Disclosure: Change in book value of the   HTML     31K 
                equipment (Tables)                                               
51: R35         Revenue Disclosure: Schedule of Revenue and         HTML     32K 
                Associated Costs (Tables)                                        
52: R36         Distribution Rights Disclosure: Black-Scholes       HTML     28K 
                Option pricing model (Tables)                                    
53: R37         Distribution Rights Disclosure: Schedule of loss    HTML     28K 
                on reacquisition of the distribution rights                      
                (Tables)                                                         
54: R38         Notes and Advances Payable Disclosure: Schedule of  HTML     42K 
                Short-term Loans and Advances Outstanding (Tables)               
55: R39         Share Capital Disclosure: Schedule of Stock Option  HTML     34K 
                Activity (Tables)                                                
56: R40         Share Capital Disclosure: Schedule of Stock         HTML     29K 
                Options Outstanding (Tables)                                     
57: R41         Share Capital Disclosure: Schedule of Warrant       HTML     34K 
                Activity (Tables)                                                
58: R42         Share Capital Disclosure: Schedule of Warrant       HTML     31K 
                Details (Tables)                                                 
59: R43         Income Taxes Disclosure: Schedule of Effective      HTML     34K 
                Income Tax Rate Reconciliation (Tables)                          
60: R44         Income Taxes Disclosure: Schedule of Deferred Tax   HTML     32K 
                Assets and Liabilities (Tables)                                  
61: R45         Organization and Nature of Operations (Details)     HTML     27K 
62: R46         Related Party Transactions Disclosure: Schedule of  HTML     40K 
                Amounts Due to Related Parties (Details)                         
63: R47         Related Party Transactions Disclosure: Schedule of  HTML     36K 
                Transactions with Related Parties (Details)                      
64: R48         Inventory Disclosure (Details)                      HTML     31K 
65: R49         Other Current Assets Disclosure (Details)           HTML     28K 
66: R50         Equipment Disclosure: Change in book value of the   HTML     34K 
                equipment (Details)                                              
67: R51         Revenue Disclosure: Schedule of Revenue and         HTML     49K 
                Associated Costs (Details)                                       
68: R52         Distribution Rights Disclosure (Details)            HTML     28K 
69: R53         Notes and Advances Payable Disclosure: Schedule of  HTML     46K 
                Short-term Loans and Advances Outstanding                        
                (Details)                                                        
70: R54         Notes and Advances Payable Disclosure (Details)     HTML     72K 
71: R55         Share Capital Disclosure (Details)                  HTML     83K 
72: R56         Share Capital Disclosure: Schedule of Stock Option  HTML     38K 
                Activity (Details)                                               
73: R57         Share Capital Disclosure: Schedule of Stock         HTML     32K 
                Options Outstanding (Details)                                    
74: R58         Share Capital Disclosure: Schedule of Warrant       HTML     32K 
                Activity (Details)                                               
75: R59         Share Capital Disclosure: Schedule of Warrant       HTML     36K 
                Details (Details)                                                
76: R60         Income Taxes Disclosure: Schedule of Effective      HTML     51K 
                Income Tax Rate Reconciliation (Details)                         
77: R61         Income Taxes Disclosure: Schedule of Deferred Tax   HTML     34K 
                Assets and Liabilities (Details)                                 
78: R62         Income Taxes Disclosure (Details)                   HTML     27K 
79: R63         Subsequent Events Disclosure (Details)              HTML     40K 
81: XML         IDEA XML File -- Filing Summary                      XML    148K 
16: XML         XBRL Instance -- cmxc-20210531_htm                   XML    727K 
80: EXCEL       IDEA Workbook of Financial Reports                  XLSX     73K 
11: EX-101.CAL  XBRL Calculations -- cmxc-20210531_cal               XML     73K 
12: EX-101.DEF  XBRL Definitions -- cmxc-20210531_def                XML    332K 
13: EX-101.LAB  XBRL Labels -- cmxc-20210531_lab                     XML    566K 
14: EX-101.PRE  XBRL Presentations -- cmxc-20210531_pre              XML    519K 
15: EX-101.SCH  XBRL Schema -- cmxc-20210531                         XSD    192K 
82: JSON        XBRL Instance as JSON Data -- MetaLinks              229±   331K 
83: ZIP         XBRL Zipped Folder -- 0001393905-21-000393-xbrl      Zip    155K 

‘EX-21.1’   —   List of Significant Subsidiaries

This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]

13 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/15/24  Cell MedX Corp.                   10-Q        2/29/24   53:2.7M                                   Empire Stock Transf… Inc
 1/16/24  Cell MedX Corp.                   10-Q       11/30/23   46:2.3M                                   Empire Stock Transf… Inc
10/16/23  Cell MedX Corp.                   10-Q        8/31/23   42:1.9M                                   Empire Stock Transf… Inc
 9/01/23  Cell MedX Corp.                   10-K        5/31/23   73:3.2M                                   Empire Stock Transf… Inc
 6/29/23  Cell MedX Corp.                   10-Q        2/28/23   53:2.5M                                   Empire Stock Transf… Inc
 5/19/23  Cell MedX Corp.                   10-Q       11/30/22   53:2.4M                                   Empire Stock Transf… Inc
 4/19/23  Cell MedX Corp.                   10-Q        8/31/22   51:2.2M                                   Empire Stock Transf… Inc
 4/07/23  Cell MedX Corp.                   10-K        5/31/22   90:3.6M                                   Empire Stock Transf… Inc
 4/11/22  Cell MedX Corp.                   10-Q        2/28/22   56:2.5M                                   Empire Stock Transf… Inc
 1/12/22  Cell MedX Corp.                   10-Q       11/30/21   54:2.4M                                   Empire Stock Transf… Inc
10/14/21  Cell MedX Corp.                   424B3                  1:365K                                   Empire Stock Transf… Inc
10/14/21  Cell MedX Corp.                   10-Q        8/31/21   50:2.2M                                   Empire Stock Transf… Inc
10/12/21  Cell MedX Corp.                   424B3                  1:705K                                   Empire Stock Transf… Inc

18 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/26/21  Cell MedX Corp.                   8-K:1,3,7,9 5/24/21    4:95K                                    Empire Stock Transf… Inc
 4/09/21  Cell MedX Corp.                   10-Q        2/28/21   56:2.8M                                   Empire Stock Transf… Inc
 1/14/21  Cell MedX Corp.                   10-Q       11/30/20   53:2M                                     Empire Stock Transf… Inc
 9/15/20  Cell MedX Corp.                   10-K        5/31/20   84:2.9M                                   Empire Stock Transf… Inc
 4/14/20  Cell MedX Corp.                   10-Q        2/29/20   67:2.2M                                   Empire Stock Transf… Inc
 1/31/20  Cell MedX Corp.                   8-K:1,9     1/29/20    3:69K                                    Empire Stock Transf… Inc
 1/14/20  Cell MedX Corp.                   10-Q       11/30/19   65:2.2M                                   Empire Stock Transf… Inc
12/31/18  Cell MedX Corp.                   8-K:1,3,9  12/27/18    3:248K                                   Empire Stock Transf… Inc
 9/13/18  Cell MedX Corp.                   10-K        5/31/18   85:3M                                     Empire Stock Transf… Inc
10/17/17  Cell MedX Corp.                   10-Q        8/31/17   59:2.2M                                   Empire Stock Transf… Inc
 8/11/15  Cell MedX Corp.                   8-K:5,9     8/11/15    3:172K                                   Ideal Connection, Inc/FA
11/18/14  Cell MedX Corp.                   8-K:1,9    11/13/14    2:48K                                    Ideal Connection, Inc/FA
11/03/14  Cell MedX Corp.                   8-K:1,9    10/28/14    2:60K                                    Ideal Connection, Inc/FA
10/17/14  Cell MedX Corp.                   8-K:1,9    10/16/14    3:407K                                   Ideal Connection, Inc/FA
10/09/14  Cell MedX Corp.                   10-Q        8/31/14   37:2.9M                                   Ideal Connection, Inc/FA
 8/26/14  Cell MedX Corp.                   10-K        5/31/14   37:1.8M                                   Ideal Connection, Inc/FA
10/13/10  Cell MedX Corp.                   S-1/A                  8:1.2M                                   Toppan Merrill/FA
 7/13/10  Cell MedX Corp.                   S-1                   11:921K                                   Toppan Merrill/FA